USE OF MULLERIAN INHIBITING SUBSTANCE FOR TREATING TUMORS AND FOR MODULATING CLASS 1 MAJOR HISTOCOMPATIBILITY ANTIGEN EXPRESSION - Patent 0646010

(19)

(11)

EP 0 646 010 A1

(12)

(43)	Date of publication:
	05.04.1995 Bulletin 1995/14

(21)	Application number: 93916585.0

(22)	Date of filing: 18.06.1993

(51)

International Patent Classification (IPC):

C07K 14/ 575^{( . )}
A61K 38/ 00^{( . )}

C07K 16/ 26^{( . )}
A61K 48/ 00^{( . )}

(86)	International application number:
	PCT/US1993/005791

(87)	International publication number:
	WO 1994/000133 (06.01.1994 Gazette 1994/02)

(84)	Designated Contracting States:
	CH DE DK ES FR GB IE IT LI NL PT SE

(30)

Priority:

19.06.1992 US 19920901637
21.01.1993 US 19930007125

(71)	Applicant: THE GENERAL HOSPITAL CORPORATION
	Boston, MA 02114 (US)

(72)	Inventors:
	DONAHOE, Patricia K. Weston, MA 02193 (US) CHIN, Tai Wai Taipei, Taiwan 112 (TW) PARRY, Robert L. Silver Spring, MD 20910 (US) EPSTEIN, James Boston, MA 02114 (US) RAGIN, Richard C. Boston, MA 02135 (US) MACLAUGHLIN, David T. Saugus, MA 01906 (US) BARKSDALE, Edward M. Cincinnati, OH 45236 (US)

(74)	Representative: White, Martin Paul, et al
	Kilburn & Strode, 30 John Street London WC1N 2DD London WC1N 2DD (GB)

(54)	USE OF MULLERIAN INHIBITING SUBSTANCE FOR TREATING TUMORS AND FOR MODULATING CLASS 1 MAJOR HISTOCOMPATIBILITY ANTIGEN EXPRESSION